Updated: Apr 4, 2024
Based on 4 analysts giving stock ratings to Mineralys Therapeutics in the past 3 months
Strong Buy
Buy
Hold
Sell
Updated: Apr 4, 2024
The average Mineralys Therapeutics stock price target is 31.50 with a max estimate of 36.00 and a min estimate of 27.00
Review Mineralys Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Apr 4, 2024
Strong Buy
Buy
Hold
Sell
Updated: Apr 4, 2024